Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 7.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.09 | 52 Week High | $9.58 | |||
| Open | $7.09 | 52 Week Low | $2.34 | |||
| Day High | $7.09 | P/E | N/A | |||
| Day Low | $7.09 | EPS | $-0.34 | |||
| Volume | 386 | |||||
